UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • Role Of Indigenous And Inoculated Trichoderma Spp. In Managing Soilborne Fungal Diseases

    Trichoderma is a versatile fungal organism known to function in both disease control and plant growth promotion.

  • Digital Pathology Solutions for low-budget and low-tech regions of the world

    Digital pathology is transforming possibilities for patient care and the nature of pathologists’ work.

  • Acrylamide, Plant Genomics And The Food Industry

    Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…

  • Will the intersection of blockchain and AI inspire the Pharma R&D Renaissance?

    One of its great strengths of blockchain is its great weakness: the fact that the ledger is immutable.

CE and HPLC applications for rAAV characterisation

Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.

Read More

Vertically transmitted endophyte improved plant-rhizobacteria interaction

Plant growth-promoting bacteria (PGPB) have been identified as potential biofertilizers, eco-friendly, renewable and have been demonstrated to actively restore soil fertility. Beyond this, they have been shown to be a promising biological resource to augment chemical fertilizer, and drastically reduce its application and subsequent negative effects.

Read More

The future of GMOs, gene editing and plant biotechnology in post-Brexit UK

Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.

Read More

Sustainably Improving Crop Yield and Composition through Enhanced Photosynthesis

Understandably, one of the main themes of the recent Plant Genomics & Gene Editing Congress: USA was how research and industry can enable farmers and plant growers to meet the growing challenges of global food security. In his presentation, Greg Bryan introduced us to ZeaKal, a photosynthesis company developing solutions for farmers.

Read More

Improving the selection of candidate CD8+ T cell epitopes for immunotherapy

Alongside the talks at our conferences, the poster presentations are a huge part of the knowledge sharing that takes place. We’re thrilled to be able to take a closer look at this poster from the Research & Technology Series, presented by Wim van Esch and the team at Sanquin.

Read More

A look back at 2019’s Federal Regulatory Update on Plant Biostimulants

On June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

Acrylamide, Plant Genomics and the Food Industry

Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…

Read More

Phytobiomes Alliance: Convergent Research & Regulatory Science Activities

Kellye Eversole told us that “a major paradigm shift in agricultural production is required to meet the demands of a global world population projected to reach 9.7 billion in 2050. We have to increase crop productivity sustainably while preserving biodiversity, natural resources, and grower income in the context of climate change.”

Read More

CE and HPLC applications for rAAV characterisation

Despite recent advances in the gene therapy field, significant challenges lie ahead for the consistent manufacturing and release of these medicines. Analytical methods and automation need to keep pace as more medicines move towards the market and more quality control resources are required. Well-developed methods on robust platforms will be crucial to ensure the quality of these novel medicines for the doctors and patients who need them.

Read More

Improving the selection of candidate CD8+ T cell epitopes for immunotherapy

Alongside the talks at our conferences, the poster presentations are a huge part of the knowledge sharing that takes place. We’re thrilled to be able to take a closer look at this poster from the Research & Technology Series, presented by Wim van Esch and the team at Sanquin.

Read More

Inspirata and Cirdan Announce New Technical Partnership at the Digital Pathology & AI Congress

At the 6th Digital Pathology & AI Congress, Inspirata and Cirdan announced their new technical partnership designed to empower NHS clinical laboratories to accelerate their use of digital pathology.

Read More

Ireland and the Future of Biopharmaceutical Manufacturing

Ahead of the 3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress in Dublin, we consider how Ireland is uniquely positioned to play a significant role in the next generation of biopharmaceutical manufacturing and delivery of life changing medicines. 

Read More

The Future is Bright for Microbiome Metabolites and Drugs Derived From Probiotics

Some of the claims made about Probiotics can be hard to believe, and often even harder to reliably prove. However, the science surrounding the development of these products is exciting, and some of the more extraordinary claims can be quantified.

Here a few examples from some of the presentations at the Microbiome & Prebiotics Series: USA:

Read More

The Future is Bright for Probiotics

I am extremely sceptical of all claims about probiotics. For the last 10 years of running Probiotics.org, companies have been sending me questionable products with extraordinarily impossible to believe claims.

But, after Global Engage’s 4th Probiotic & Prebiotics Congress, here’s what I strongly believe:

Read More

3 Ways Single-Cell Sequencing and AI are Transforming Kidney Transplantation

Transplantation is now a successful therapy for end-stage renal disease (ESRD). The first successful kidney transplantation happened in Boston in 1954 and the procedure is now routine clinical practice in more than 80 countries worldwide.

Ishita Moghe and Kim Solez outline some of the major strides taken in kidney pathology and transplantation through the use of scRNA-seq and Artificial Intelligence (AI). 

Read More

Slides from the 4th Medicinal Chemistry & Protein Degradation Summit

The 4th Medicinal Chemistry & Protein Degradation Summit provided two days of fascinating topics and case studies about AI-assisted lead optimisation, DNA encoded libraries and the use of data and informatics in drug-discovery. We have made the following presentation slides available from Greg Makara, Paul Colbon and Yugal Sharma.

Read More

Vertically transmitted endophyte improved plant-rhizobacteria interaction

Plant growth-promoting bacteria (PGPB) have been identified as potential biofertilizers, eco-friendly, renewable and have been demonstrated to actively restore soil fertility. Beyond this, they have been shown to be a promising biological resource to augment chemical fertilizer, and drastically reduce its application and subsequent negative effects.

Read More

The future of GMOs, gene editing and plant biotechnology in post-Brexit UK

Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.

Read More

Sustainably Improving Crop Yield and Composition through Enhanced Photosynthesis

Understandably, one of the main themes of the recent Plant Genomics & Gene Editing Congress: USA was how research and industry can enable farmers and plant growers to meet the growing challenges of global food security. In his presentation, Greg Bryan introduced us to ZeaKal, a photosynthesis company developing solutions for farmers.

Read More

A look back at 2019’s Federal Regulatory Update on Plant Biostimulants

On June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

Acrylamide, Plant Genomics and the Food Industry

Ahead of the 8th Plant Genomics and Gene Editing Congress, we asked keynote speaker Nigel Halford, Principal Research Scientist at Rothamsted Research, UK, to share with us the background to his research…

Read More

Phytobiomes Alliance: Convergent Research & Regulatory Science Activities

Kellye Eversole told us that “a major paradigm shift in agricultural production is required to meet the demands of a global world population projected to reach 9.7 billion in 2050. We have to increase crop productivity sustainably while preserving biodiversity, natural resources, and grower income in the context of climate change.”

Read More

Role of indigenous and inoculated Trichoderma spp. in managing soilborne fungal diseases

David Butler is Associate Professor at the University of Tennessee, USA. His research focuses on soil-plant and soil-plant-microbe relationships in horticultural cropping systems. In particular, David is interested in understanding non-chemical and biological soil disinfestation techniques and their mechanisms of pathogen control, the effect of alternative soil disinfestation practices on soil fertility and crop nutrition, and the how the nutrient cycle dynamics of annual and perennial cover crops can alter to improve crop nutrition.

Read More

Presentation Slides from the 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA

At the recent 4th Partnerships in Biocontrol, Biostimulants & Microbiome Congress: USA we heard a number of interesting presentations on how plant and soil microbiome research is identifying microbes to enhance crop productivity and disease resistance.

Thanks to some of our speakers, we have made the following slides discussing the current regulatory landscape from Sarah Caffery, Keith Matthews, and Terry Stone available to view.

Read More

Examining Blockchain Systems & Designing Smart Contracts

The blockchain has the potential to enable the collaboration between patients, researchers, and care providers to provide individualised care for patients, but how can this technology be harnessed in a practical way?

This was one of the key questions that was asked at the Blockchain in Healthcare Congress and we had the pleasure of welcoming an array of expert speakers from pharma, academia, and industry to provide the answer.

Read More

The role of extrinsic motivation in sports and physical activity

Motivation is one of the most significant psychological concepts in many areas of life – from work and education to achieving personal goals. In sports and physical activity, motivation plays an especially important part due to the fact that, to millions of people worldwide, staying fit and active is not an obligation or a professional prerequisite, but rather a personal goal. Blockchain technology, together with elements of gamification, may actually help people achieve this goal.

Read More

Conciliating Blockchain and GDPR

Aurélie Bayle is a Data Protection Officer at be-ys: a role she considers to be at the heart of the new legal framework for any company.

Before GDPR came into effect on 25th May 2018, she was working towards global compliance, which involved completing all the steps given by the Article 29 Data Protection Working Party, an advisory board made up of a representative from the data authority of each EU Member State, the European Data Protection Supervisor, and the European Commission. Her duties have included auditing the structures and processes, preparing the data protection impact assessments, checking the compliance of processing activities, analysing the risks of the processing in the medical area, preparing new processes and policies about data protection, and asking data processors about their own compliance.

Read More

When Blockchain Meets the Right to be Forgotten: Technology Versus Law

Over the past few years, the popularity of the blockchain and cryptocurrencies has increased and has reached important notoriety, not only in scientific and IT journals, but also in the media. Although there are many kinds of cryptocurrencies in circulation nowadays, the most popular is Bitcoin.

Read More

Supporting Blockchain Startups: An Open Letter from Katherine Merton

Dear colleagues,

The blockchain technology market is expected to grow to 2.3 billion US dollars by 2021, from 339.5 million US dollars in 2017. [1] With an annual growth rate of 61.5%, it is one of the fastest growing technologies in the healthcare industry.

Read More

The Big List of Microfluidics Companies & Investors

The microfluidic-based devices market has been growing since 2014 due to the increasing point of care testing demand and the miniaturisation of microfluidic chips. 

Read More

What will we do with all this data?

The amount of data we are creating every day has increased exponentially to match the rise in use of smart and connected devices. The internet of things has connected every aspect of our lives to the digital realm: most of these devices operate by tracking your habits, movements, preferences, voice, and more, then logging those habits online. Specifically, the collection of health data has become abundant, because most people now have or wear some sort of device to track daily patterns, steps, cycles, and more. Even our phones often default to track these things for us, whether we choose to enable the function or not.

Read More

How Standards & Standardised Infrastructure Fuel Innovation

It might surprise a lot of people to learn that standards can be viewed as a tool to support innovation, to set businesses free and to focus on the core of their product where their expertise lie. When working with the use of electronic communication systems within the entire healthcare sector, the main focal point is often ensuring a good support for collaboration and work processes.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive